Investor Alert: Crescent Biopharma Executives Sell Shares – What It Means for Your Portfolio
Investors should watch Crescent Biopharma’s June 22 insider sales—under Rule 10b5‑1, a coordinated move that may signal upcoming capital‑raising or strategic shifts while the company’s strong cash, hematology pipeline and regulatory approvals offer …
4 minutes to read